.png)
Case Series/Study
Non-healing wounds develop as a result of varying etiologies including disease, surgery, and trauma. These wounds are often difficult to manage, and many times require advanced treatment options. A synthetic hybrid-scale fiber matrix* is becoming increasingly popular as an option due to its versatility and effectiveness in treating various wounds. The current study investigates the efficacy of the synthetic hybrid-scale fiber matrix in the treatment of non-healing wounds of varying etiologies.
Methods:
A retrospective analysis of 7 patients with a total of 7 wounds was conducted. Patients were treated with the synthetic hybrid-scale fiber matrix and wound healing progress was observed. The synthetic hybrid-scale fiber matrix was reapplied as deemed appropriate.
Results:
The average patient age was 68 years old. Patients had multiple co-morbidities including venous insufficiency, hypertension, hyperlipidemia, breast carcinoma, and chronic kidney disease. Various wounds were treated in this study, including venous leg ulcers, hematoma, and atypical post-surgical wounds. Four out of 7 wounds closed 7 weeks after initial treatment with the synthetic hybrid-scale fiber matrix. The 3 patients that did not achieve total wound closure developed 80 – 90% regranulation of the wound bed, resolved undermining and tunneling, as well as significant decrease in wound area of up to 65%. The average number of synthetic matrix applications was 5.6.
Discussion:
Use of the synthetic hybrid-scale fiber matrix demonstrated wound re-epithelialization and regranulation across various wound types and in the presence of multiple patient co-morbidities. Overall, this case series suggests that synthetic hybrid-scale fiber matrix can be utilized to help achieve appropriate clinical outcomes, whether that be total wound closure or wound bed regranulation.
Trademarked Items: *Restrata® Acera Surgical, Inc., St. Louis, Missouri
References: